Literature DB >> 17217148

Prophylaxis and treatment of venous thromboembolism in patients with cancer: an update.

Michela Falciani1, Davide Imberti, Domenico Prisco.   

Abstract

The close correlation between venous thromboembolism (VTE) and cancer has been known for some time, and numerous reports in the literature have highlighted the epidemiological significance. Moreover, VTE has a substantial impact on morbidity and mortality in oncological patients. The prevention and treatment of VTE are important aspects of the clinical management of patients with cancer. The presence of a tumour is often associated with thrombotic complications that are more difficult to diagnose, and sometimes make the treatment of VTE less effective and more likely to cause haemorrhages.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17217148     DOI： 10.1007/BF02934760

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


  30 in total

1.  Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.

Authors:  P Mismetti; S Laporte; J Y Darmon; A Buchmüller; H Decousus
Journal:  Br J Surg       Date:  2001-07       Impact factor: 6.939

2.  Home-treatment of deep vein thrombosis in patients with cancer.

Authors:  Walter Ageno; Rebecca Grimwood; Sara Limbiati; Francesco Dentali; Luigi Steidl; Philip S Wells
Journal:  Haematologica       Date:  2005-02       Impact factor: 9.941

Review 3.  Treatment of venous thromboembolism in cancer patients.

Authors:  M N Levine; A Y Lee
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

4.  Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.

Authors:  Melina Verso; Giancarlo Agnelli; Sergio Bertoglio; Franco C Di Somma; Francesco Paoletti; Walter Ageno; Mario Bazzan; Pasquale Parise; Roberto Quintavalla; Emanuele Naglieri; Armando Santoro; Davide Imberti; Mariella Sorarù; Stefano Mosca
Journal:  J Clin Oncol       Date:  2005-03-14       Impact factor: 44.544

Review 5.  Venous thromboembolism and cancer: prevention of VTE.

Authors:  D Bergqvist
Journal:  Thromb Res       Date:  2001-06-15       Impact factor: 3.944

Review 6.  Cancer and venous thromboembolism: an overview.

Authors:  P Prandoni; A Piccioli; A Girolami
Journal:  Haematologica       Date:  1999-05       Impact factor: 9.941

7.  The effect of low molecular weight heparin on survival in patients with advanced malignancy.

Authors:  Clara P W Klerk; Susanne M Smorenburg; Hans-Martin Otten; Anthonie W A Lensing; Martin H Prins; Franco Piovella; Paolo Prandoni; Monique M E M Bos; Dick J Richel; Geertjan van Tienhoven; Harry R Büller
Journal:  J Clin Oncol       Date:  2005-02-07       Impact factor: 44.544

8.  Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

Authors:  Ajay K Kakkar; Mark N Levine; Zbigniew Kadziola; Nicholas R Lemoine; Vanessa Low; Heman K Patel; Gordon Rustin; Michael Thomas; Mary Quigley; Robin C N Williamson
Journal:  J Clin Oncol       Date:  2004-05-15       Impact factor: 44.544

9.  Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

Authors:  Paolo Prandoni; Anthonie W A Lensing; Andrea Piccioli; Enrico Bernardi; Paolo Simioni; Bruno Girolami; Antonio Marchiori; Paola Sabbion; Martin H Prins; Franco Noventa; Antonio Girolami
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

10.  Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study.

Authors:  Guy Meyer; Zora Marjanovic; Judith Valcke; Bernard Lorcerie; Yves Gruel; Philippe Solal-Celigny; Christine Le Maignan; Jean Marc Extra; Paul Cottu; Dominique Farge
Journal:  Arch Intern Med       Date:  2002 Aug 12-26
View more
  4 in total

Review 1.  Prophylaxis and treatment of venous thromboembolism in patients with cancer.

Authors:  Walter Ageno; Alessandro Squizzato
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 2.  Prevention of venous thromboembolism in acutely ill medical patients after the results of recent trials with the new oral anticoagulants.

Authors:  Davide Imberti; Raffaella Benedetti; Walter Ageno
Journal:  Intern Emerg Med       Date:  2013-07-16       Impact factor: 3.397

3.  A prospective study on survival in cancer patients with and without venous thromboembolism.

Authors:  Giancarlo Agnelli; Melina Verso; Mario Mandalà; Silvano Gallus; Claudio Cimminiello; Giovanni Apolone; Giovanni Di Minno; Evaristo Maiello; Paolo Prandoni; Armando Santoro; Lucio Crinò; Roberto Labianca
Journal:  Intern Emerg Med       Date:  2013-08-14       Impact factor: 3.397

4.  Cardiovascular oncology: a new discipline inside internal medicine?

Authors:  Domenico Prisco; Mario Milco D'Elios; Caterina Cenci; Lucia Ciucciarelli; Carlo Tamburini
Journal:  Intern Emerg Med       Date:  2014-03-19       Impact factor: 3.397
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.